Protalix BioTherapeutics, Inc. (PLX) › Total LiabilitiesProtalix BioTherapeutics, Inc. (PLX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2010: $76.05M2011: $77.88M2012: $82.08M2013: $140.28M2014: $133.96M2015: $86.38M2016: $92.20M2017: $101.67M2018: $114.01M2019: $115.71M2020: $94.97M2021: $79.70M2022: $66.43M2023: $50.87M2024: $30.21M2025: $34.12M$34.12M2010Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$34.12M+12.9%2024$30.21M-40.6%2023$50.87M-23.4%2022$66.43M-16.7%2021$79.70M-16.1%2020$94.97M-17.9%2019$115.71M+1.5%2018$114.01M+12.1%2017$101.67M+10.3%2016$92.20M+6.7%2015$86.38M-35.5%2014$133.96M-4.5%2013$140.28M+70.9%2012$82.08M+5.4%2011$77.88M+2.4%2010$76.05M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share